Reuters logo
Bayer Phase III trial shows effectiveness of fat-reducing drug
February 1, 2013 / 10:46 AM / 5 years ago

Bayer Phase III trial shows effectiveness of fat-reducing drug

FRANKFURT, Feb 1 (Reuters) - German drugmaker Bayer said results of two Phase III trials showed ATX-101, an injectable drug to reduce fat deposits under the chin, was effective as a non-surgical treatment. (Reporting by Christoph Steitz)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below